An Outbreak of Neuroangiostrongyliasis (Rat Lungworm Disease) in Hawai‘i: Evidence Supporting the Early Use of Albendazole–Corticosteroid Co-Therapy
The American Journal of Tropical Medicine and Hygiene · 2026
DOI: 10.4269/ajtmh.25-0689 ↗Kurz gefasst
Fallbericht in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2026. Verfasst von Vernon Ansdell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, H…. Hauptthemen laut MEDLINE: Adrenal Cortex Hormones, Albendazole, Anthelmintics, Disease Outbreaks. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neuroangiostrongyliasis (NAS) is an emerging parasitic infection caused by the neurotropic nematode Angiostrongylus cantonensis ( A. cantonensis ). It is the leading infectious etiology of eosinophilic meningitis worldwide. In 2017, six men living on Hawai‘i Island developed NAS after drinking homemade kava. After the event, a dead slug, likely infected with A. cantonensis , was found at the bottom of a communal vessel. Neuroangiostrongyliasis was subsequently confirmed in three patients through polymerase chain reaction testing of their cerebrospinal fluid. Two patients were presumptively diagnosed with NAS on the basis of highly suggestive signs and symptoms, the presence of eosinophilic meningitis, and a shared history of exposure. A lumbar puncture was unsuccessful in one patient, who was presumptively diagnosed with NAS on the basis of his symptoms and shared exposure history. Five of six patients received at least 2 weeks of co-therapy with albendazole and corticosteroids, which was initiated within 15 days of infection. The treatment was well-tolerated, and no significant adverse events were noted. One patient who did not have health insurance completed only two doses of albendazole because of the cost of the drug and experienced symptom recurrence on several occasions. This rare, common-source outbreak of A. cantonensis infection supports the early use of albendazole–corticosteroid co-therapy in proven or suspected cases of NAS. It also provides additional evidence for the water transmissibility of this parasite.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, Hawai'i.
- Daniel K. Inouye College of Pharmacy, University of Hawai'i at Hilo, Hilo, Hawai'i.
- Hawai'i Department of Health, Hazard Evaluation and Emergency Response Office, Pearl City, Hawai'i.
- Hawai'i Permanente Medical Group, Honolulu, Hawai'i.
Zitieren
APA
Ansdell, V., Jacob, J., Gosnell, W. L., McMillan, J. K. P., Yates, J., Lteif, L., Bicakci, D., Kaufusi, P. H., & Kramer, K. (2026). An Outbreak of Neuroangiostrongyliasis (Rat Lungworm Disease) in Hawai‘i: Evidence Supporting the Early Use of Albendazole–Corticosteroid Co-Therapy. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.25-0689
Vancouver
Ansdell V, Jacob J, Gosnell WL, McMillan JKP, Yates J, Lteif L, et al. An Outbreak of Neuroangiostrongyliasis (Rat Lungworm Disease) in Hawai‘i: Evidence Supporting the Early Use of Albendazole–Corticosteroid Co-Therapy. The American Journal of Tropical Medicine and Hygiene. 2026. doi:10.4269/ajtmh.25-0689
BibTeX
@article{Ansdell2026,
author = {Ansdell, Vernon and Jacob, John and Gosnell, William L and McMillan, Jourdan K P and Yates, Johnnie and Lteif, Louis and Bicakci, Deniz and Kaufusi, Pakieli H and Kramer, Kenton},
title = {An Outbreak of Neuroangiostrongyliasis (Rat Lungworm Disease) in Hawai‘i: Evidence Supporting the Early Use of Albendazole–Corticosteroid Co-Therapy},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2026},
doi = {10.4269/ajtmh.25-0689}
}
EUVIMED